AAAAAA

   
Results: 1-13 |
Results: 13
HIV-RELATED NON-HODGKINS-LYMPHOMA - CHOP INDUCTION THERAPY AND INTERFERON-ALPHA-2B ZIDOVUDINE MAINTENANCE THERAPY/
Authors: WEISS R HUHN D MITROU P NERL C SCHURMANN D SCHEIDEGGER C KNAUF W TRENN G KRONAWITTER U VANLUNZEN J ARASTEH K HERBST H
Citation: R. Weiss et al., HIV-RELATED NON-HODGKINS-LYMPHOMA - CHOP INDUCTION THERAPY AND INTERFERON-ALPHA-2B ZIDOVUDINE MAINTENANCE THERAPY/, Leukemia & lymphoma, 29(1-2), 1998, pp. 103-118
AUTOLOGOUS BMT PBSCT IN PATIENTS WITH BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA/
Authors: MARTIN H ATTA J FAUTH F OTTMANN OG OTT MG WASSMANN B BERGMANN L KNAUF W GRAMATZKI M ZANDER A BUNJES D ARNOLD R HOELZER D
Citation: H. Martin et al., AUTOLOGOUS BMT PBSCT IN PATIENTS WITH BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA/, Bone marrow transplantation, 21, 1998, pp. 5-5
LEUKEMIC ARTHRITIS AND CYTOKINES - PREDOMINANT ROLE OF INTERLEUKIN-1-BETA SECRETED BY AN OVEREXPANDED B-CELL CLONE
Authors: RUDWAFEIT M ELIAS F HUMALIOKI T NEURE L KNAUF W STEIN H DISTLER A SIEPER J BEREK C BRAUN J
Citation: M. Rudwafeit et al., LEUKEMIC ARTHRITIS AND CYTOKINES - PREDOMINANT ROLE OF INTERLEUKIN-1-BETA SECRETED BY AN OVEREXPANDED B-CELL CLONE, Arthritis and rheumatism, 41(9), 1998, pp. 1188-1188
OVEREXPANDED B-CELL CLONE MEDIATING LEUKEMIC ARTHRITIS BY ABUNDANT SECRETION OF INTERLEUKIN-1-BETA - A CASE-REPORT
Authors: RUDWALEIT M ELIAS F HUMALJOKI T NEURE L KNAUF W STEIN H DISTLER A SIEPER J BEREK C BRAUN J
Citation: M. Rudwaleit et al., OVEREXPANDED B-CELL CLONE MEDIATING LEUKEMIC ARTHRITIS BY ABUNDANT SECRETION OF INTERLEUKIN-1-BETA - A CASE-REPORT, Arthritis and rheumatism, 41(9), 1998, pp. 1695-1700
HIV-RELATED NON-HODGKINS-LYMPHOMA - CHOP INDUCTION THERAPY AND INTERFERON-A-2B ZIDOVUDINE MAINTENANCE THERAPY/
Authors: WEISS R HUHN D MITROU P NERL C SHURMANN D SCHEIDEGGER C KNAUF W TRENN G KRONAWITTER U VANLUNZEN J ARASTEH K HERBST H
Citation: R. Weiss et al., HIV-RELATED NON-HODGKINS-LYMPHOMA - CHOP INDUCTION THERAPY AND INTERFERON-A-2B ZIDOVUDINE MAINTENANCE THERAPY/, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 91-91
INITIAL EXPERIENCE WITH DYNAMIC MR-IMAGING IN EVALUATION OF NORMAL BONE-MARROW VERSUS MALIGNANT BONE-MARROW INFILTRATIONS IN HUMANS
Authors: BOLLOW M KNAUF W KORFEL A TAUPITZ M SCHILLING A WOLF KJ HAMM B
Citation: M. Bollow et al., INITIAL EXPERIENCE WITH DYNAMIC MR-IMAGING IN EVALUATION OF NORMAL BONE-MARROW VERSUS MALIGNANT BONE-MARROW INFILTRATIONS IN HUMANS, Journal of magnetic resonance imaging, 7(1), 1997, pp. 241-250
MYCOPHENOLATE MOFETIL FOR SEVERE AUTOIMMUNE HEMOLYTIC-ANEMIA
Authors: ZIMMERMOLSBERGER B KNAUF W THIEL E
Citation: B. Zimmermolsberger et al., MYCOPHENOLATE MOFETIL FOR SEVERE AUTOIMMUNE HEMOLYTIC-ANEMIA, Lancet, 350(9083), 1997, pp. 1003-1004
FATAL MUCOR PNEUMONIA AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE FORNON-HODGKINS-LYMPHOMA
Authors: SZELENYI H FOSS HD KREUSER ED KNAUF W THIEL E
Citation: H. Szelenyi et al., FATAL MUCOR PNEUMONIA AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE FORNON-HODGKINS-LYMPHOMA, Annals of hematology, 73(3), 1996, pp. 145-147
CLINICAL-RESULTS AND IMMUNE PARAMETERS AFTER TREATMENT WITH CYTOSTATICS AND INTERFERON-ALPHA (IFN-ALPHA) IN HIV-RELATED NON-HODGKINS-LYMPHOMAS (HIV-NHL)
Authors: HUHN D WEISS R MITROU P NERL C SCHURMANN D SCHEIDEGGER C KNAUF W TRENN G KRONAWITTER U VANLUNZEN J HERBST H
Citation: D. Huhn et al., CLINICAL-RESULTS AND IMMUNE PARAMETERS AFTER TREATMENT WITH CYTOSTATICS AND INTERFERON-ALPHA (IFN-ALPHA) IN HIV-RELATED NON-HODGKINS-LYMPHOMAS (HIV-NHL), Experimental hematology, 24(9), 1996, pp. 741-741
MULTICENTER PROSPECTIVE RANDOMIZED TRIAL OF FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (CAP) FOR TREATMENT OF ADVANCED-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: FENAUX P BINET JL LEPORRIER M TRAVADE P PIGUET H LINASSIER C DESABLENS B DREYFUS B BRIZARD CP MURGUE B RUSSET T SOUTEYRAND P JOHNSON S PHILLIPS MJ HIDDEMANN W SMITH A ROATH S LOFFLER H BJORKHOLM M OSBY E EMMERICH B COIFFIER B THIEL E KNAUF W JULIUSSON G MARCUS R PRENTICE AG COPPLESTONE JA FREUND M MILLIGAN PW WINFIELD D YIN J HELLRIEGEL KP HOSSFELD DK KIMBY E BURNETT AK LISTER TA LUCIE N KANZ L LERNER R LINDEMALM C CHILD A HAMBLIN T OSCIER D SMITH JG SINGER RJ PARKER A WHITTAKER J WYLD P SMITH AG
Citation: P. Fenaux et al., MULTICENTER PROSPECTIVE RANDOMIZED TRIAL OF FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (CAP) FOR TREATMENT OF ADVANCED-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA, Lancet, 347(9013), 1996, pp. 1432-1438
INTERFERON-ALPHA-2B (IFN-ALPHA) FOR EARLY-PHASE CHRONIC LYMPHOCYTIC-LEUKEMIA WITH HIGH-RISK FOR DISEASE PROGRESSION - RESULTS OF A RANDOMIZED MULTICENTER STUDY
Authors: LANGENMAYER I NERL C KNAUF W DEMPSTER S HALLEK M ADORF D DIETZFELBINGER H BUSCH R ZIEGLERHEITBROCK HW THIEL E EMMERICH B
Citation: I. Langenmayer et al., INTERFERON-ALPHA-2B (IFN-ALPHA) FOR EARLY-PHASE CHRONIC LYMPHOCYTIC-LEUKEMIA WITH HIGH-RISK FOR DISEASE PROGRESSION - RESULTS OF A RANDOMIZED MULTICENTER STUDY, British Journal of Haematology, 94(2), 1996, pp. 362-369
RISK-ADAPTED TREATMENT OF HIV-RELATED HIGH-GRADE NON-HODGKINS-LYMPHOMAS WITH CHOP FOLLOWED BY IFN-ALPHA MAINTENANCE THERAPY
Authors: KNAUF W WEISS R NERL C SCHURMANN D VANLUNZEN J MITROU PS HUHN D
Citation: W. Knauf et al., RISK-ADAPTED TREATMENT OF HIV-RELATED HIGH-GRADE NON-HODGKINS-LYMPHOMAS WITH CHOP FOLLOWED BY IFN-ALPHA MAINTENANCE THERAPY, Blood, 84(10), 1994, pp. 10000163-10000163
FLUDARABINE SINGLE-AGENT THERAPY FOR RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II STUDY OF THE GERMAN LOW-GRADE NON-HODGKINS-LYMPHOMA STUDY-GROUP
Authors: HIDDEMANN W UNTERHALT M POTT C WORMANN B SANDFORD D FREUND M ENGERT A GASSMANN W HOLTKAMP W SEUFERT J HELLRIEGEL KP KNAUF W EMMERICH B KANZ L KOCH P
Citation: W. Hiddemann et al., FLUDARABINE SINGLE-AGENT THERAPY FOR RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II STUDY OF THE GERMAN LOW-GRADE NON-HODGKINS-LYMPHOMA STUDY-GROUP, Seminars in oncology, 20(5), 1993, pp. 28-31
Risultati: 1-13 |